Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Urtoxazumab

(Synonyms: TMA-15, HuVTm1.1) Copy Product Info
🥰Excellent

Synonyms: TMA-15, HuVTm1.1

Catalog No. T80888 Copy Product Info
🥰Excellent
Urtoxazumab (TMA-15) is a humanized monoclonal antibody that targets Shiga toxin 2 (Stx2) [1].
Urtoxazumab
Cas No. 502496-16-4
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiry4-6 weeks4-6 weeks
5 mgInquiry4-6 weeks4-6 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Urtoxazumab (TMA-15) is a humanized monoclonal antibody that targets Shiga toxin 2 (Stx2) [1].
In vivo
Urtoxazumab (TMA-15) administered at a dosage ranging from 0.25 to 2.5 mg/kg via a single injection improves the lethality rate in B2F1 mice infected with [1] in a time- and dose-dependent manner.
SynonymsTMA-15, HuVTm1.1
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
TargetStx2
Chemical Properties
Cas No.502496-16-4
Storage & Solubility Information
Storage-20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion
Related Tags: Urtoxazumab in vivo